129 related articles for article (PubMed ID: 23102497)
1. Deficient mismatch repair phenotype is a prognostic factor for colorectal cancer in elderly patients.
Aparicio T; Schischmanoff O; Poupardin C; Soufir N; Angelakov C; Barrat C; Levy V; Choudat L; Cucherousset J; Boubaya M; Lagorce C; Guetz GD; Wind P; Benamouzig R
Dig Liver Dis; 2013 Mar; 45(3):245-50. PubMed ID: 23102497
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.
Lugli A; Vlajnic T; Giger O; Karamitopoulou E; Patsouris ES; Peros G; Terracciano LM; Zlobec I
Hum Pathol; 2011 Dec; 42(12):1833-40. PubMed ID: 21664647
[TBL] [Abstract][Full Text] [Related]
3. Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer.
Minoo P; Baker K; Baumhoer D; Terracciano L; Lugli A; Zlobec I
Hum Pathol; 2010 Jan; 41(1):70-8. PubMed ID: 19740518
[TBL] [Abstract][Full Text] [Related]
4. Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.
Jover R; Zapater P; Castells A; Llor X; Andreu M; Cubiella J; Piñol V; Xicola RM; Bujanda L; Reñé JM; Clofent J; Bessa X; Morillas JD; Nicolás-Pérez D; Payá A; Alenda C;
Gut; 2006 Jun; 55(6):848-55. PubMed ID: 16299036
[TBL] [Abstract][Full Text] [Related]
5. Strategy in clinical practice for classification of unselected colorectal tumours based on mismatch repair deficiency.
Jensen LH; Lindebjerg J; Byriel L; Kolvraa S; Crüger DG
Colorectal Dis; 2008 Jun; 10(5):490-7. PubMed ID: 17868408
[TBL] [Abstract][Full Text] [Related]
6. Tumor Grade Is Prognostically Relevant Among Mismatch Repair Deficient Colorectal Carcinomas.
Johncilla M; Chen Z; Sweeney J; Yantiss RK
Am J Surg Pathol; 2018 Dec; 42(12):1686-1692. PubMed ID: 30179899
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of β-2-microglobulin expression in colorectal cancers stratified by mismatch repair status.
Koelzer VH; Baker K; Kassahn D; Baumhoer D; Zlobec I
J Clin Pathol; 2012 Nov; 65(11):996-1002. PubMed ID: 22859396
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status.
Jover R; Zapater P; Castells A; Llor X; Andreu M; Cubiella J; Balaguer F; Sempere L; Xicola RM; Bujanda L; Reñé JM; Clofent J; Bessa X; Morillas JD; Nicolás-Pérez D; Pons E; Payá A; Alenda C;
Eur J Cancer; 2009 Feb; 45(3):365-73. PubMed ID: 18722765
[TBL] [Abstract][Full Text] [Related]
9. Defective mismatch repair status as a prognostic biomarker of disease-free survival in stage III colon cancer patients treated with adjuvant FOLFOX chemotherapy.
Zaanan A; Fléjou JF; Emile JF; Des GG; Cuilliere-Dartigues P; Malka D; Lecaille C; Validire P; Louvet C; Rougier P; de Gramont A; Bonnetain F; Praz F; Taïeb J
Clin Cancer Res; 2011 Dec; 17(23):7470-8. PubMed ID: 21998335
[TBL] [Abstract][Full Text] [Related]
10. Molecular biology from bench-to-bedside - which colorectal cancer patients should be referred for genetic counselling and risk assessment.
Jensen LH; Dysager L; Lindebjerg J; Kølvrå S; Byriel L; Crüger DG
Eur J Cancer; 2010 Jul; 46(10):1823-8. PubMed ID: 20417091
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of deficient mismatch repair phenotype and the V600E BRAF mutation in elderly patients with colorectal cancer.
Aparicio T; Schischmanoff O; Poupardin C; Mary F; Soufir N; Barrat C; Bellaiche G; Boubaya M; Choudat L; Cucherousset J; DesGuetz G; Wind P; Benamouzig R
J Geriatr Oncol; 2014 Oct; 5(4):384-8. PubMed ID: 25176643
[TBL] [Abstract][Full Text] [Related]
13. Microsatellite instability, prognosis and drug sensitivity of stage II and III colorectal cancer: more complexity to the puzzle.
Tejpar S; Saridaki Z; Delorenzi M; Bosman F; Roth AD
J Natl Cancer Inst; 2011 Jun; 103(11):841-4. PubMed ID: 21597023
[No Abstract] [Full Text] [Related]
14. BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis.
Kalady MF; Dejulius KL; Sanchez JA; Jarrar A; Liu X; Manilich E; Skacel M; Church JM
Dis Colon Rectum; 2012 Feb; 55(2):128-33. PubMed ID: 22228154
[TBL] [Abstract][Full Text] [Related]
15. Mucinous differentiation in colorectal cancer--indicator of poor prognosis?
Langner C; Harbaum L; Pollheimer MJ; Kornprat P; Lindtner RA; Schlemmer A; Vieth M; Rehak P
Histopathology; 2012 Jun; 60(7):1060-72. PubMed ID: 22348346
[TBL] [Abstract][Full Text] [Related]
16. Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer.
Malesci A; Laghi L; Bianchi P; Delconte G; Randolph A; Torri V; Carnaghi C; Doci R; Rosati R; Montorsi M; Roncalli M; Gennari L; Santoro A
Clin Cancer Res; 2007 Jul; 13(13):3831-9. PubMed ID: 17606714
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability in sporadic colon carcinomas has no independent prognostic value in a Belgian study population.
Deschoolmeester V; Van Damme N; Baay M; Claes K; Van Marck E; Baert FJ; Wuyts W; Cabooter M; Weyler J; Vermeulen P; Lardon F; Vermorken JB; Peeters M
Eur J Cancer; 2008 Oct; 44(15):2288-95. PubMed ID: 18707864
[TBL] [Abstract][Full Text] [Related]
18. No difference in the occurrence of mismatch repair defects and APC and CTNNB1 genes mutation in a multi-racial colorectal carcinoma patient cohort.
Tan LP; Ng BK; Balraj P; Lim PK; Peh SC
Pathology; 2007 Apr; 39(2):228-34. PubMed ID: 17454753
[TBL] [Abstract][Full Text] [Related]
19. Loss of SIRT1 histone deacetylase expression associates with tumour progression in colorectal adenocarcinoma.
Jang SH; Min KW; Paik SS; Jang KS
J Clin Pathol; 2012 Aug; 65(8):735-9. PubMed ID: 22554968
[TBL] [Abstract][Full Text] [Related]
20. Low microsatellite instability is associated with poor prognosis in stage C colon cancer.
Kohonen-Corish MR; Daniel JJ; Chan C; Lin BP; Kwun SY; Dent OF; Dhillon VS; Trent RJ; Chapuis PH; Bokey EL
J Clin Oncol; 2005 Apr; 23(10):2318-24. PubMed ID: 15800322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
